BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 27035974)

  • 1. [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.
    Kim W; Le TM; Wei L; Poddar S; Bazzy J; Wang X; Uong NT; Abt ER; Capri JR; Austin WR; Van Valkenburgh JS; Steele D; Gipson RM; Slavik R; Cabebe AE; Taechariyakul T; Yaghoubi SS; Lee JT; Sadeghi S; Lavie A; Faull KF; Witte ON; Donahue TR; Phelps ME; Herschman HR; Herrmann K; Czernin J; Radu CG
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4027-32. PubMed ID: 27035974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.
    Lee JT; Campbell DO; Satyamurthy N; Czernin J; Radu CG
    J Nucl Med; 2012 Feb; 53(2):275-80. PubMed ID: 22302964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel PET probes specific for deoxycytidine kinase.
    Shu CJ; Campbell DO; Lee JT; Tran AQ; Wengrod JC; Witte ON; Phelps ME; Satyamurthy N; Czernin J; Radu CG
    J Nucl Med; 2010 Jul; 51(7):1092-8. PubMed ID: 20554721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Biodistribution and Radiation Dosimetry of
    Barrio MJ; Spick C; Radu CG; Lassmann M; Eberlein U; Allen-Auerbach M; Schiepers C; Slavik R; Czernin J; Herrmann K
    J Nucl Med; 2017 Mar; 58(3):374-378. PubMed ID: 27811125
    [No Abstract]   [Full Text] [Related]  

  • 5. Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway.
    Schwarzenberg J; Radu CG; Benz M; Fueger B; Tran AQ; Phelps ME; Witte ON; Satyamurthy N; Czernin J; Schiepers C
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):711-21. PubMed ID: 21127859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the mechanism of cytotoxicity of 2-chloro-9-(2-deoxy-2- fluoro-beta-D-arabinofuranosyl)adenine, 2-chloro-9-(2-deoxy-2-fluoro- beta-D-ribofuranosyl)adenine, and 2-chloro-9-(2-deoxy-2,2-difluoro- beta-D-ribofuranosyl)adenine in CEM cells.
    Parker WB; Shaddix SC; Rose LM; Shewach DS; Hertel LW; Secrist JA; Montgomery JA; Bennett LL
    Mol Pharmacol; 1999 Mar; 55(3):515-20. PubMed ID: 10051535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
    Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
    Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation.
    Zhang Y; Secrist JA; Ealick SE
    Acta Crystallogr D Biol Crystallogr; 2006 Feb; 62(Pt 2):133-9. PubMed ID: 16421443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Imaging of Deoxycytidine Kinase Activity Using Deoxycytidine-Enhanced CEST MRI.
    Han Z; Li Y; Zhang J; Liu J; Chen C; van Zijl PC; Liu G
    Cancer Res; 2019 May; 79(10):2775-2783. PubMed ID: 30940660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and preclinical pharmacology of a novel dCK inhibitor, DI-87.
    Poddar S; Capparelli EV; Rosser EW; Gipson RM; Wei L; Le T; Jung ME; Radu C; Nikanjam M
    Biochem Pharmacol; 2020 Feb; 172():113742. PubMed ID: 31812677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.
    Nagai S; Takenaka K; Nachagari D; Rose C; Domoney K; Sun D; Sparreboom A; Schuetz JD
    Cancer Res; 2011 Mar; 71(5):1781-91. PubMed ID: 21245102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
    Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
    Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
    Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
    Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new pyrimidine-specific reporter gene: a mutated human deoxycytidine kinase suitable for PET during treatment with acycloguanosine-based cytotoxic drugs.
    Likar Y; Zurita J; Dobrenkov K; Shenker L; Cai S; Neschadim A; Medin JA; Sadelain M; Hricak H; Ponomarev V
    J Nucl Med; 2010 Sep; 51(9):1395-403. PubMed ID: 20810757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography.
    Laing RE; Walter MA; Campbell DO; Herschman HR; Satyamurthy N; Phelps ME; Czernin J; Witte ON; Radu CG
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2847-52. PubMed ID: 19196993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of immune responses after immunotherapy in glioblastoma using PET and MRI.
    Antonios JP; Soto H; Everson RG; Moughon DL; Wang AC; Orpilla J; Radu C; Ellingson BM; Lee JT; Cloughesy T; Phelps ME; Czernin J; Liau LM; Prins RM
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10220-10225. PubMed ID: 28874539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin overcomes resistance to clofarabine in two leukemic cell lines by increased expression of deoxycytidine kinase.
    Yamanishi M; Narazaki H; Asano T
    Exp Hematol; 2015 Mar; 43(3):207-14. PubMed ID: 25461250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase.
    Zhu C; Johansson M; Permert J; Karlsson A
    Biochem Pharmacol; 1998 Oct; 56(8):1035-40. PubMed ID: 9776315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography.
    Murphy JM; Armijo AL; Nomme J; Lee CH; Smith QA; Li Z; Campbell DO; Liao HI; Nathanson DA; Austin WR; Lee JT; Darvish R; Wei L; Wang J; Su Y; Damoiseaux R; Sadeghi S; Phelps ME; Herschman HR; Czernin J; Alexandrova AN; Jung ME; Lavie A; Radu CG
    J Med Chem; 2013 Sep; 56(17):6696-708. PubMed ID: 23947754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Analysis of Human Nucleoside Kinase-Based Reporter Systems for PET Imaging.
    Lee JT; Zhang H; Moroz MA; Likar Y; Shenker L; Sumzin N; Lobo J; Zurita J; Collins J; van Dam RM; Ponomarev V
    Mol Imaging Biol; 2017 Feb; 19(1):100-108. PubMed ID: 27393689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.